EGFR and its ligands have been shown to be expressed in the majority of GISTs and is known to canonically activate downstream pathways, including RAS/MAPK and PI3K/AKT [37], that are also overrepresented in GIST [22]. This evidence concerns the gene AKT1 and gastrointestinal stromal tumor.